Meyer T

ORCID: 0000-0003-3425-4546 · 3 papers in corpus
2020
JAMA oncology ·doi:10.1001/jamaoncol.2020.0001

ImportanceThe overall low survival rate of patients with lung cancer calls for improved detection tools to enable better treatment options and improved patient outcomes. Multivariable molecular signatures, such as blood-borne microRNA (miRN…

2006
Molecular cancer ·doi:10.1186/1476-4598-5-30

BackgroundCarcinogenesis is a multi-step process indicated by several genes up- or down-regulated during tumor progression. This study examined and identified differentially expressed genes in cutaneous squamous cell carcinoma (SCC).Results…

2000
British journal of cancer ·doi:10.1054/bjoc.2000.1174

Currently the only tumour marker to have a well-defined and validated role in the management of ovarian cancer is CA125. Changes in the level of CA125 can be used as a reliable indication of response or progression according to various crit…